<?xml version="1.0" encoding="UTF-8"?><abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:dn="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85135551182</prism:url><dc:identifier>SCOPUS_ID:85135551182</dc:identifier><eid>2-s2.0-85135551182</eid><pubmed-id>35941298</pubmed-id><prism:doi>10.1007/s11274-022-03371-9</prism:doi><article-number>178</article-number><dc:title>Recent advances in utilization of ferredoxins for biosynthesis of valuable compounds</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><citedby-count>0</citedby-count><prism:publicationName>World Journal of Microbiology and Biotechnology</prism:publicationName><dc:publisher>Springer Science and Business Media B.V.</dc:publisher><source-id>16152</source-id><prism:issn>15730972 09593993</prism:issn><prism:volume>38</prism:volume><prism:issueIdentifier>10</prism:issueIdentifier><prism:coverDate>2022-10-01</prism:coverDate><openaccess>0</openaccess><openaccessFlag>false</openaccessFlag><dc:creator><author seq="1" auid="57833749900"><ce:initials>S.</ce:initials><ce:indexed-name>Kim S.</ce:indexed-name><ce:surname>Kim</ce:surname><ce:given-name>Seongwon</ce:given-name><preferred-name><ce:initials>S.</ce:initials><ce:indexed-name>Kim S.</ce:indexed-name><ce:surname>Kim</ce:surname><ce:given-name>Seongwon</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/57833749900</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author></dc:creator><dc:description><abstract xmlns="" original="y" xml:lang="eng"><publishercopyright>Â© 2022, The Author(s), under exclusive licence to Springer Nature B.V.</publishercopyright><ce:para>Ferredoxin (Fd) is a small metalloprotein holding one or two Fe-S clusters in its inner shell. Like many other metalloproteins, Fd is redox active and involved in electron transfer during cellular metabolism. The electrons from reduced Fd are mostly used to regenerate NADPH under physiological conditions. Increasing number of attempts have been reported, however, where Fd delivers electrons to enable biosynthesis of valuable compounds. Various compounds ranging from H<inf>2</inf> to vitamin D<inf>3</inf> have been synthesized successfully using electrons mediated by Fd molecules. In this review, we provide an overview of the engineering studies utilizing Fd for biosynthesis of targeted molecules. The emphasis is on the role and activity of Fd as well as the methods used to improve the rate of electron transfer. Both microbial and electrochemical biosynthesis technologies are described and compared with respect to productivity and the compound being produced. In addition to the ferredoxins from the microbial organisms, artificially designed de novo types are described, highlighting the potential of the emerging computational methods used in metabolic and protein engineering. We believe that the recent advances in utilization of Fd for biosynthesis can result in breakthrough innovation across the biotechnology industry.</ce:para></abstract></dc:description><link href="https://api.elsevier.com/content/abstract/scopus_id/85135551182" rel="self"/><link href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85135551182&amp;origin=inward" rel="scopus"/><link href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85135551182&amp;origin=inward" rel="scopus-citedby"/></coredata><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"><affilname>Carnegie Mellon University</affilname><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation id="60017776" href="https://api.elsevier.com/content/affiliation/affiliation_id/60017776"><affilname>Hongik University</affilname><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><authors><author seq="1" auid="57833749900"><ce:initials>S.</ce:initials><ce:indexed-name>Kim S.</ce:indexed-name><ce:surname>Kim</ce:surname><ce:given-name>Seongwon</ce:given-name><preferred-name><ce:initials>S.</ce:initials><ce:indexed-name>Kim S.</ce:indexed-name><ce:surname>Kim</ce:surname><ce:given-name>Seongwon</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/57833749900</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author><author seq="2" auid="24776042000"><ce:initials>J.</ce:initials><ce:indexed-name>Koo J.</ce:indexed-name><ce:surname>Koo</ce:surname><ce:given-name>Jamin</ce:given-name><preferred-name><ce:initials>J.</ce:initials><ce:indexed-name>Koo J.</ce:indexed-name><ce:surname>Koo</ce:surname><ce:given-name>Jamin</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/24776042000</author-url><affiliation id="60017776" href="https://api.elsevier.com/content/affiliation/affiliation_id/60017776"/></author></authors></abstracts-retrieval-response>